Beiersdorf AG’s major dermatological initiatives in the US over the next six months include the first Eucerin Face range in Target doors, the early 2025 debut of an anti-pigment ingredient that is already propelling growth abroad, and a major relaunch of Nivea Body.
Eucerin Face, Anti-Pigment Ingredient Among Derm Innovations Hitting US Market – Beiersdorf
Marking a first for the iconic brand, Eucerin Face is rolling out in Target doors now, Beiersdorf leaders noted in a 7 August half-year earnings presentation. The firm’s Consumer business segment recorded nominal sales growth of 5.4% to €4.3bn in the first half of 2024, led by Nivea.
More from Earnings
• By
Coty Inc. reports fiscal second quarter sales slipped 3% on a reported basis to $1.67bn, reflecting further slowing of the mass beauty market, particularly color cosmetics.
• By
L’Oréal Groupe expects total sales in 2025 to beat 4%-4.5% growth anticipated for the overall beauty market, with US population growth, planned innovations boding well across its beauty businesses.
• By
Cincinnati-based P&G reports its antiperspirants/deodorants business is a ‘pocket of strength,’ growing 11% in the US in the fiscal second quarter and helping lift overall beauty sales as skin care stumbles.
New York-based International Flavors & Fragrances, Inc.’s Scent division is undertaking R&D in natural, synthetic chemistry and biotech molecules, says CEO Erik Fyrwald during a third quarter earnings presentation 6 November.
More from New Products
• By
L’Oréal Group unveils Cell BioPrint, a hardware device that provides personalized skin analysis in just five minutes, while Shiseido and Samsung win innovation awards for their digital beauty devices during the Consumer Technology Association’s Consumer Electronics Show in Las Vegas.
• By
Xytogen Biotech’s Factorfive stem cell-based skin care delivers benefits that are greater than the company claims, says founder and CEO John Aylworth. Available mostly through clinicians’ offices, the formulas are based on a proprietary process that triggers stem cells to send out growth factor signals, which are captured in a ‘conditioned media’ and used as the basis for products.
• By
Bayer adds dry eye treatment to its Bepanthen skin care range; Stada launches special edition Elotrans supplement for Eintracht Frankfurt fans; Hermes offers chewable magnesium supplement; and Klosterfrau introduces Oyono Night extension to help troubled sleepers maintain their immunity.